- Home
- PRTG vs FCUV Comparison
PRTG vs FCUV Comparison
Compare PRTG & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTG
- FCUV
- Stock Information
- Founded
- PRTG N/A
- FCUV 2012
- Country
- PRTG British Virgin Islands
- FCUV United States
- Employees
- PRTG N/A
- FCUV N/A
- Industry
- PRTG Oil & Gas Production
- FCUV Industrial Machinery/Components
- Sector
- PRTG Energy
- FCUV Industrials
- Exchange
- PRTG Nasdaq
- FCUV Nasdaq
- Market Cap
- PRTG 17.7M
- FCUV 16.7M
- IPO Year
- PRTG N/A
- FCUV N/A
- Fundamental
- Price
- PRTG $5.45
- FCUV $2.16
- Analyst Decision
- PRTG
- FCUV
- Analyst Count
- PRTG 0
- FCUV 0
- Target Price
- PRTG N/A
- FCUV N/A
- AVG Volume (30 Days)
- PRTG 62.1K
- FCUV 58.8K
- Earning Date
- PRTG 09-16-2025
- FCUV 11-06-2025
- Dividend Yield
- PRTG N/A
- FCUV N/A
- EPS Growth
- PRTG N/A
- FCUV N/A
- EPS
- PRTG N/A
- FCUV N/A
- Revenue
- PRTG N/A
- FCUV $432,983.00
- Revenue This Year
- PRTG N/A
- FCUV N/A
- Revenue Next Year
- PRTG N/A
- FCUV N/A
- P/E Ratio
- PRTG N/A
- FCUV N/A
- Revenue Growth
- PRTG N/A
- FCUV 140.82
- 52 Week Low
- PRTG $2.81
- FCUV $1.80
- 52 Week High
- PRTG $23.01
- FCUV $10.90
- Technical
- Relative Strength Index (RSI)
- PRTG 32.25
- FCUV 45.98
- Support Level
- PRTG $6.80
- FCUV $1.87
- Resistance Level
- PRTG $9.43
- FCUV $2.75
- Average True Range (ATR)
- PRTG 0.97
- FCUV 0.21
- MACD
- PRTG -0.36
- FCUV 0.08
- Stochastic Oscillator
- PRTG 9.57
- FCUV 37.48
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.